These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16893879)

  • 1. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis.
    Roessler M; Rollinger W; Mantovani-Endl L; Hagmann ML; Palme S; Berndt P; Engel AM; Pfeffer M; Karl J; Bodenmüller H; Rüschoff J; Henkel T; Rohr G; Rossol S; Rösch W; Langen H; Zolg W; Tacke M
    Mol Cell Proteomics; 2006 Nov; 5(11):2092-101. PubMed ID: 16893879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics identification of desmin as a potential oncofetal diagnostic and prognostic biomarker in colorectal cancer.
    Ma Y; Peng J; Liu W; Zhang P; Huang L; Gao B; Shen T; Zhou Y; Chen H; Chu Z; Zhang M; Qin H
    Mol Cell Proteomics; 2009 Aug; 8(8):1878-90. PubMed ID: 19460759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of actin beta-like 2 (ACTBL2) as novel, upregulated protein in colorectal cancer.
    Ghazanfar S; Fatima I; Aslam M; Musharraf SG; Sherman NE; Moskaluk C; Fox JW; Akhtar MW; Sadaf S
    J Proteomics; 2017 Jan; 152():33-40. PubMed ID: 27989943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneous nuclear ribonucleoprotein A1 is identified as a potential biomarker for colorectal cancer based on differential proteomics technology.
    Ma YL; Peng JY; Zhang P; Huang L; Liu WJ; Shen TY; Chen HQ; Zhou YK; Zhang M; Chu ZX; Qin HL
    J Proteome Res; 2009 Oct; 8(10):4525-35. PubMed ID: 19715280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Differentially Expressed Proteins in the Serum of Colorectal Cancer Patients Using 2D-DIGE Proteomics Analysis.
    Lim LC; Looi ML; Zakaria SZ; Sagap I; Rose IM; Chin SF; Jamal R
    Pathol Oncol Res; 2016 Jan; 22(1):169-77. PubMed ID: 26463353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of S100A8 and S100A9 as serological markers for colorectal cancer.
    Kim HJ; Kang HJ; Lee H; Lee ST; Yu MH; Kim H; Lee C
    J Proteome Res; 2009 Mar; 8(3):1368-79. PubMed ID: 19186948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and verification of heat shock protein 60 as a potential serum marker for colorectal cancer.
    Hamelin C; Cornut E; Poirier F; Pons S; Beaulieu C; Charrier JP; Haïdous H; Cotte E; Lambert C; Piard F; Ataman-Önal Y; Choquet-Kastylevsky G
    FEBS J; 2011 Dec; 278(24):4845-59. PubMed ID: 21973086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rat-to-human search for proteomic alterations reveals transgelin as a biomarker relevant to colorectal carcinogenesis and liver metastasis.
    Peng J; Zhang Q; Ma Y; Wang Y; Huang L; Zhang P; Chen J; Qin H
    Electrophoresis; 2009 Sep; 30(17):2976-2987. PubMed ID: 19711377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of IMPDH2 as a tumor-associated antigen in colorectal cancer using immunoproteomics analysis.
    He Y; Mou Z; Li W; Liu B; Fu T; Zhao S; Xiang D; Wu Y
    Int J Colorectal Dis; 2009 Nov; 24(11):1271-9. PubMed ID: 19597826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays.
    Babel I; Barderas R; Díaz-Uriarte R; Martínez-Torrecuadrada JL; Sánchez-Carbayo M; Casal JI
    Mol Cell Proteomics; 2009 Oct; 8(10):2382-95. PubMed ID: 19638618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of HSP27 as a potential tumor marker for colorectal cancer by the two-dimensional polyacrylamide gel electrophoresis.
    Liu W; Ma Y; Huang L; Peng J; Zhang P; Zhang H; Chen J; Qin H
    Mol Biol Rep; 2010 Oct; 37(7):3207-16. PubMed ID: 19842058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer.
    Roessler M; Rollinger W; Palme S; Hagmann ML; Berndt P; Engel AM; Schneidinger B; Pfeffer M; Andres H; Karl J; Bodenmüller H; Rüschoff J; Henkel T; Rohr G; Rossol S; Rösch W; Langen H; Zolg W; Tacke M
    Clin Cancer Res; 2005 Sep; 11(18):6550-7. PubMed ID: 16166432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteasome activator subunit 3 promotes pancreatic cancer growth via c-Myc-glycolysis signaling axis.
    Guo J; Hao J; Jiang H; Jin J; Wu H; Jin Z; Li Z
    Cancer Lett; 2017 Feb; 386():161-167. PubMed ID: 27756569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gel-Based Proteomics of Clinical Samples Identifies Potential Serological Biomarkers for Early Detection of Colorectal Cancer.
    Thorsen SF; Gromova I; Christensen IJ; Fredriksson S; Andersen CL; Nielsen HJ; Stenvang J; Moreira JMA
    Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of serum proteins as prognostic and predictive markers of colorectal cancer using surface enhanced laser desorption ionization-time of flight mass spectrometry.
    Helgason HH; Engwegen JY; Zapatka M; Vincent A; Cats A; Boot H; Beijnen JH; Schellens JH
    Oncol Rep; 2010 Jul; 24(1):57-64. PubMed ID: 20514444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognosis value of proteasome activator subunit 3 expression in gastric cancer.
    Chen ZM; Kai Z; Fang J; Chen Y; Fang YF; Hu SJ
    J Physiol Pharmacol; 2022 Jun; 73(3):. PubMed ID: 36515625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein pattern difference in the colon cancer cell lines examined by two-dimensional differential in-gel electrophoresis and mass spectrometry.
    Katayama M; Nakano H; Ishiuchi A; Wu W; Oshima R; Sakurai J; Nishikawa H; Yamaguchi S; Otsubo T
    Surg Today; 2006; 36(12):1085-93. PubMed ID: 17123137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Searching for serum tumor markers for colorectal cancer using a 2-D DIGE approach.
    Ma Y; Peng J; Huang L; Liu W; Zhang P; Qin H
    Electrophoresis; 2009 Aug; 30(15):2591-9. PubMed ID: 19637221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of differentially-expressed proteins between early submucosal non-invasive and invasive colorectal cancer using 2D-DIGE and mass spectrometry.
    Zhang J; Song MQ; Zhu JS; Zhou Z; Xu ZP; Chen WX; Chen NW
    Int J Immunopathol Pharmacol; 2011; 24(4):849-59. PubMed ID: 22230392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of melanotransferrin as a serological marker of colorectal cancer by secretome analysis and quantitative proteomics.
    Shin J; Kim HJ; Kim G; Song M; Woo SJ; Lee ST; Kim H; Lee C
    J Proteome Res; 2014 Nov; 13(11):4919-31. PubMed ID: 25216327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.